Drug Development and Industrial Pharmacy

Papers
(The H4-Index of Drug Development and Industrial Pharmacy is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
In vivo behavior of technetium-99m labeled ibuprofen in infection and inflamation animal models67
Formulation, biopharmaceutical evaluation and in-vitro screening of polyherbal phytosomes for breast cancer therapy51
Development and characterization of 3D printed ethylene vinyl acetate (EVA) as drug delivery device for the treatment of overactive bladder38
Preparation and evaluation of liposome with ropivacaine ion-pairing in local pain management28
A QbD approach for optimizing the lyophilization parameters of cyclophosphamide monohydrate25
Establishing virtual bioequivalence and bio-related dissolution specifications for naproxen using physiologically based pharmacokinetic modeling and in vitro biorelevant24
Microneedle-assisted transdermal delivery of amlodipine besylate loaded nanoparticles24
Studies on ameliorative potentials of quercetin nanoparticles against imidacloprid induced subacute genotoxicity and histopathological alteration in Swiss albino mice18
Ginkgolic acid as a fusion inhibitor: targeting RBD-ACE2 interaction with in silico, in vitro evidence of allosteric modulation and potent virucidal effect18
Polymeric implants with drug-releasing capabilities: a mapping review of laboratory research18
Polycaprolactone and polycaprolactone triol blends to obtain a stable liquid nanotechnological formulation: synthesis, characterization and in vitro – in vivo taste masking evaluation17
Improving cellular uptake and synergetic anti-tumor effects of magnolol and Brucea javanica oil through self-microemulsion17
Assessing the viability of carbamoylethyl pullulan-g-stearic acid based smart polymeric micelles for tumor targeting of raloxifene17
Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model16
Polymyxin B and silver nanoparticles: a nanotechnology-driven approach to overcome antibiotic resistance15
0.062453985214233